Zhou X - Search Results

1

Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2.

Fang Z, Peng L, Lucas C, Lin Q, Zhou L, Yang L, Feng Y, Ren P, Renauer PA, Monteiro VS, Hahn AM, Park JJ, Zhou X; Yale SARS-CoV-2 Genomic Surveillance Initiative; Grubaugh ND, Wilen CB, Chen S. Fang Z, et al. Among authors: zhou x, zhou l. Cell Discov. 2022 Jul 19;8(1):69. doi: 10.1038/s41421-022-00435-w. Cell Discov. 2022. PMID: 35853867 Free PMC article. No abstract available.

2

Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T Cells.

Dong MB, Wang G, Chow RD, Ye L, Zhu L, Dai X, Park JJ, Kim HR, Errami Y, Guzman CD, Zhou X, Chen KY, Renauer PA, Du Y, Shen J, Lam SZ, Zhou JJ, Lannin DR, Herbst RS, Chen S. Dong MB, et al. Among authors: zhou x, zhou jj. Cell. 2019 Aug 22;178(5):1189-1204.e23. doi: 10.1016/j.cell.2019.07.044. Cell. 2019. PMID: 31442407 Free PMC article.

3

Tumor immunology CRISPR screening: present, past, and future.

Dong MB, Tang K, Zhou X, Zhou JJ, Chen S. Dong MB, et al. Among authors: zhou x, zhou jj. Trends Cancer. 2022 Mar;8(3):210-225. doi: 10.1016/j.trecan.2021.11.009. Epub 2021 Dec 15. Trends Cancer. 2022. PMID: 34920978 Free PMC article. Review.

4

Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2.

Peng L, Renauer PA, Ökten A, Fang Z, Park JJ, Zhou X, Lin Q, Dong MB, Filler R, Xiong Q, Clark P, Lin C, Wilen CB, Chen S. Peng L, et al. Among authors: zhou x. Cell Rep Med. 2022 May 17;3(5):100634. doi: 10.1016/j.xcrm.2022.100634. Epub 2022 Apr 26. Cell Rep Med. 2022. PMID: 35561673 Free PMC article.

5

Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species.

Peng L, Fang Z, Renauer PA, McNamara A, Park JJ, Lin Q, Zhou X, Dong MB, Zhu B, Zhao H, Wilen CB, Chen S. Peng L, et al. Among authors: zhou x. Cell Rep. 2022 Aug 2;40(5):111160. doi: 10.1016/j.celrep.2022.111160. Epub 2022 Jul 19. Cell Rep. 2022. PMID: 35921835 Free PMC article.

6

Double knockout CRISPR screen for cancer resistance to T cell cytotoxicity.

Park JJ, Codina A, Ye L, Lam S, Guo J, Clark P, Zhou X, Peng L, Chen S. Park JJ, et al. Among authors: zhou x. J Hematol Oncol. 2022 Dec 1;15(1):172. doi: 10.1186/s13045-022-01389-y. J Hematol Oncol. 2022. PMID: 36456981 Free PMC article.

7

Applications of CRISPR technology in cellular immunotherapy.

Zhou X, Renauer PA, Zhou L, Fang SY, Chen S. Zhou X, et al. Among authors: zhou l. Immunol Rev. 2023 Nov;320(1):199-216. doi: 10.1111/imr.13241. Epub 2023 Jul 14. Immunol Rev. 2023. PMID: 37449673 Review.

8

CTLA-4 tail fusion enhances CAR-T antitumor immunity.

Zhou X, Cao H, Fang SY, Chow RD, Tang K, Majety M, Bai M, Dong MB, Renauer PA, Shang X, Suzuki K, Levchenko A, Chen S. Zhou X, et al. Nat Immunol. 2023 Sep;24(9):1499-1510. doi: 10.1038/s41590-023-01571-5. Epub 2023 Jul 27. Nat Immunol. 2023. PMID: 37500885

9

Transient regulatory-T-cell interruption promotes skin-resident memory T cells mediated tumor protection.

Zhao S, Wu S, Jiang S, Zhou X, Zhao G, Wang B. Zhao S, et al. Among authors: zhou x. Sci Rep. 2023 Jul 5;13(1):10898. doi: 10.1038/s41598-023-36884-w. Sci Rep. 2023. PMID: 37407600 Free PMC article.

10

Directly Converting Bulk Wood into Branch Micro-Nano Fibers to Synergistically Enhance the Strength and Toughness via Interface Engineering.

Zhang T, Wang S, Yang K, Lin L, Yang P, Zhou K, Chen W, Chen M, Zhou X. Zhang T, et al. Among authors: zhou x. Nano Lett. 2024 May 22. doi: 10.1021/acs.nanolett.4c01084. Online ahead of print. Nano Lett. 2024. PMID: 38775216

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49,079 results

Search Page